Aloxi and Extravasation - a phase IV clinical study of FDA data

Summary:

Extravasation is reported as a side effect among people who take Aloxi (palonosetron hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Decadron, and have Breast cancer.

The phase IV clinical study analyzes which people have Extravasation when taking Aloxi. It is created by eHealthMe based on reports of 8,990 people who have side effects when taking Aloxi from the FDA, and is updated regularly.

What is Aloxi?

Aloxi has active ingredients of palonosetron hydrochloride. eHealthMe is studying from 9,072 Aloxi users. Check the latest studies of Aloxi.

What is Extravasation?

Extravasation (leakage of a fluid) is found to be associated with 259 drugs and 486 conditions by eHealthMe. Check the latest studies of Extravasation.

On Jul, 20, 2026

8,990 people reported to have side effects when taking Aloxi.
Among them, 22 people (0.24%) have Extravasation.

Among these 22 people:

How long have people been on Aloxi when they have Extravasation? *

What is the gender of people who have Extravasation when taking Aloxi? *

female: 60 %
male: 40 %

What is the age of people who have Extravasation when taking Aloxi? *

What are other drugs people take besides Aloxi? *

What are other side effects people have besides Extravasation? *

Swelling: 5 people, 22.73%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 18.18%
Vision Blurred: 3 people, 13.64%
Nausea (feeling of having an urge to vomit): 3 people, 13.64%
Device Dislocation: 3 people, 13.64%
Vascular Rupture: 3 people, 13.64%
Dizziness: 3 people, 13.64%
Skeletal Injury (bone and supporting muscle injury): 3 people, 13.64%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 3 people, 13.64%
Catheter Site Related Reaction: 3 people, 13.64%

What are the existing conditions these people have? *

Breast Cancer: 4 people, 18.18%
Ovarian Cancer (cancer of ovary): 2 people, 9.09%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 9.09%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.55%
Renal Cancer Metastatic (cancer of kidney spreads to other part): 1 person, 4.55%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 4.55%
Neoplasm Malignant (cancer tumour): 1 person, 4.55%
Nausea (feeling of having an urge to vomit): 1 person, 4.55%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Aloxi and have Extravasation?

- Check whether Extravasation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aloxi:

Aloxi (9,072 reports)

Extravasation treatments and more:

Extravasation (4,227 reports)

Browse all side effects of Aloxi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Extravasation:

Extravasation (259 drugs)

Browse all the conditions that are associated with Extravasation:

Extravasation (486 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on palonosetron hydrochloride (the active ingredients of Aloxi) and Aloxi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.